SS is a soft tissue malignancy harboring t (X; 18), resulting in the fusion of two genes SS8 (at 18q11) and SSX (1, 2, or 4 at Xp11), forming the gene fusion product SS18–SSX (Stacchiotti and Van Tine, 2018). Here, SSX2 is linked to synovial sarcoma.